Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

Table 8

Results of functional response to PRRT assessed by  ⁶⁸Ga-peptide PET/CT based on clinical benefit evaluation.

	Functional response
Clinical response	CR	PR	SD	PD
Clinical benefit	—	5	16	—
SD	—	—	1	1
PD	—	—	—	9
Asymptomatic patients	1	19	7	—